Adenoid cystic carcinoma of salivary gland

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
V Various (ATC V) 2
Mechanism of action (INN-stem analysis)
Radiopharmaceutical 1 substance
Phase II: 2

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

2 trials
  • Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Academic
    LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
    2023-504699-73-00 1 country n=32
    Ended
  • Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Academic
    LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
    2023-504699-73-00 1 country n=32
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Academic 2 Phase II 0
← All indication landscapes